Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Zhiya Yu

Showing results (41-50 of 88) with videos related to

Pageof 9
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Toll-like receptors in tumor immunotherapyChrystal M Paulos, Andrew Kaiser, Claudia Wrzesinski, et al.
Cancer Research Communications|June 28, 2023
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem CellsS M Rafiqul Islam, Takuya Maeda, Naritaka Tamaoki, et al.
The Journal of Experimental Medicine|October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsLuca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2013
T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapyShi Zhong, Karolina Malecek, Laura A Johnson, et al.
Human Gene Therapy|April 4, 2014
A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancerDaniel Abate-Daga, Kiran H Lagisetty, Eric Tran, et al.
The Journal of Experimental Medicine|August 14, 2019
Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cellsPing-Hsien Lee, Tori N Yamamoto, Devikala Gurusamy, et al.
Nature Immunology|November 8, 2011
Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cellsYun Ji, Zoltan Pos, Mahadev Rao, et al.
Journal for Immunotherapy of Cancer|December 17, 2025
Selective expansion of T-cell receptor engineered T cells with increased stem-like phenotypes using neoantigen stimulationSanghyun P Kim, Noam Levin, Youngseo Jo, et al.
The Journal of Clinical Investigation|October 5, 2013
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor functionMadhusudhanan Sukumar, Jie Liu, Yun Ji, et al.
Scientific Reports|April 2, 2020
Identification of Small Molecule Enhancers of Immunotherapy for MelanomaChristopher Dextras, Myagmarjav Dashnyam, Lesley A Mathews Griner, et al.
Pageof 9

Showing results (41-50 of 88) with videos related to

Sort By:
Pageof 9
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2007
Toll-like receptors in tumor immunotherapyChrystal M Paulos, Andrew Kaiser, Claudia Wrzesinski, et al.
Cancer Research Communications|June 28, 2023
Reprogramming of Tumor-reactive Tumor-infiltrating Lymphocytes to Human-induced Pluripotent Stem CellsS M Rafiqul Islam, Takuya Maeda, Naritaka Tamaoki, et al.
The Journal of Experimental Medicine|October 6, 2005
Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cellsLuca Gattinoni, Steven E Finkelstein, Christopher A Klebanoff, et al.
Proceedings of the National Academy of Sciences of the United States of America|April 12, 2013
T-cell receptor affinity and avidity defines antitumor response and autoimmunity in T-cell immunotherapyShi Zhong, Karolina Malecek, Laura A Johnson, et al.
Human Gene Therapy|April 4, 2014
A novel chimeric antigen receptor against prostate stem cell antigen mediates tumor destruction in a humanized mouse model of pancreatic cancerDaniel Abate-Daga, Kiran H Lagisetty, Eric Tran, et al.
The Journal of Experimental Medicine|August 14, 2019
Host conditioning with IL-1β improves the antitumor function of adoptively transferred T cellsPing-Hsien Lee, Tori N Yamamoto, Devikala Gurusamy, et al.
Nature Immunology|November 8, 2011
Repression of the DNA-binding inhibitor Id3 by Blimp-1 limits the formation of memory CD8+ T cellsYun Ji, Zoltan Pos, Mahadev Rao, et al.
Journal for Immunotherapy of Cancer|December 17, 2025
Selective expansion of T-cell receptor engineered T cells with increased stem-like phenotypes using neoantigen stimulationSanghyun P Kim, Noam Levin, Youngseo Jo, et al.
The Journal of Clinical Investigation|October 5, 2013
Inhibiting glycolytic metabolism enhances CD8+ T cell memory and antitumor functionMadhusudhanan Sukumar, Jie Liu, Yun Ji, et al.
Scientific Reports|April 2, 2020
Identification of Small Molecule Enhancers of Immunotherapy for MelanomaChristopher Dextras, Myagmarjav Dashnyam, Lesley A Mathews Griner, et al.
Pageof 9